Genmab to collaborate with Californian biotech company on three drugs

Genmab now partly owns Bolt Therapeutics after investing USD 15m in the US biotech company to develop new drugs.

Photo: Tuala Hjarnø / Genmab / PR

Genmab and US Bolt Therapeutics have entered into a collaboration which could potentially yield three novel drug candidates.

The companies will start by investigating the potential of combining their respective developmental platforms. On that basis, they will identify three molecules which can potentially play a role in cancer treatments.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs